Specialty trend reached $62.25 PMPM (+11.1%), largely from utilization growth in oncology, immunology, and dermatology; ...

Two patients developed choroidal lymphoid hyperplasia associated with vision loss after starting treatment with the GLP-1 ...

Side effects like nausea, vomiting, diarrhea and constipation are common soon after starting GLP-1s or increasing the drug’s dosage. A nutrient-dense diet and regular exercise a ...

Among people with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was associated with a reduced risk of major kidney events compared with dulaglutide, primarily driven by a ...

India's injectable GLP-1 therapy market has expanded tenfold in a year, with generic semaglutide adding fresh momentum. Even ...

Weight-loss drugs such as semaglutide are effective at tackling the biological drivers of Alzheimer’s disease, a new study ...

Metabolic and bariatric surgery offers significantly greater long-term protection against heart attack, stroke and death than ...

Metabolic and bariatric surgery offers significantly greater long-term protection against heart attack, stroke and death than ...

This continuing education course details the role of GLP-1 injectables in managing chronic conditions and overweight/obesity, ...

Tirzepatide, the active ingredient behind the popular weight loss drug Zepbound and the diabetes drug Mounjaro, has more ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El ...